位置:首页 > 蛋白库 > NCF2_MOUSE
NCF2_MOUSE
ID   NCF2_MOUSE              Reviewed;         525 AA.
AC   O70145; Q3TC92; Q3U5S4;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   03-AUG-2022, entry version 171.
DE   RecName: Full=Neutrophil cytosol factor 2;
DE            Short=NCF-2;
DE   AltName: Full=67 kDa neutrophil oxidase factor;
DE   AltName: Full=NADPH oxidase activator 2;
DE   AltName: Full=Neutrophil NADPH oxidase factor 2;
DE   AltName: Full=p67-phox;
GN   Name=Ncf2 {ECO:0000312|MGI:MGI:97284}; Synonyms=Noxa2, P67phox;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1] {ECO:0000312|EMBL:BAA25650.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Myelomonocyte;
RX   PubMed=9490028; DOI=10.1046/j.1432-1327.1998.2510573.x;
RA   Mizuki K., Kadomatsu K., Hata K., Ito T., Fan Q.-W., Kage Y., Fukumaki Y.,
RA   Sakaki Y., Takeshige K., Sumimoto H.;
RT   "Functional modules and expression of mouse p40(phox) and p67(phox), SH3-
RT   domain-containing proteins involved in the phagocyte NADPH oxidase
RT   complex.";
RL   Eur. J. Biochem. 251:573-582(1998).
RN   [2] {ECO:0000312|EMBL:BAC29404.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAC29404.1}, and
RC   NOD {ECO:0000312|EMBL:BAE33191.1};
RC   TISSUE=Bone {ECO:0000312|EMBL:BAC29404.1}, Dendritic cell, Macrophage, and
RC   Urinary bladder {ECO:0000312|EMBL:BAE23254.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3] {ECO:0000312|EMBL:AAH03730.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N {ECO:0000312|EMBL:AAH03730.1};
RC   TISSUE=Mammary gland {ECO:0000312|EMBL:AAH03730.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-233; SER-324 AND SER-398, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Kidney, Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   INTERACTION WITH GBP7; NCF4 AND CYBB.
RX   PubMed=21551061; DOI=10.1126/science.1201711;
RA   Kim B.H., Shenoy A.R., Kumar P., Das R., Tiwari S., MacMicking J.D.;
RT   "A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial
RT   infection.";
RL   Science 332:717-721(2011).
CC   -!- FUNCTION: NCF2, NCF1, and a membrane bound cytochrome b558 are required
CC       for activation of the latent NADPH oxidase (necessary for superoxide
CC       production). {ECO:0000250|UniProtKB:P19878}.
CC   -!- SUBUNIT: Component of an NADPH oxidase complex composed of a
CC       heterodimer formed by the membrane proteins CYBA and CYBB and the
CC       cytosolic subunits NCF1, NCF2 and NCF4 (By similarity). Interacts with
CC       NCF4 (PubMed:21551061). Interacts (via the C-terminal SH3 domain) with
CC       NCF1 (via C-terminus). Interacts with SYTL1 and RAC1. May interact with
CC       NOXO1. Interacts with S100A8 and calprotectin (S100A8/9) (By
CC       similarity). Interacts with GBP7 (via GB1/RHD3-type G domain)
CC       (PubMed:21551061). Interacts with CYBB; the interaction is enhanced in
CC       the presence of GBP7 (PubMed:21551061). {ECO:0000250|UniProtKB:P19878,
CC       ECO:0000269|PubMed:21551061}.
CC   -!- INTERACTION:
CC       O70145; O08709: Prdx6; NbExp=3; IntAct=EBI-9550667, EBI-444895;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P19878}.
CC   -!- DOMAIN: The OPR/PB1 domain mediates the association with NCF4/p40-PHOX.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the NCF2/NOXA1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB002664; BAA25650.1; -; mRNA.
DR   EMBL; AK036379; BAC29404.1; -; mRNA.
DR   EMBL; AK137152; BAE23254.1; -; mRNA.
DR   EMBL; AK153447; BAE32002.1; -; mRNA.
DR   EMBL; AK155324; BAE33191.1; -; mRNA.
DR   EMBL; AK170839; BAE42065.1; -; mRNA.
DR   EMBL; AK171059; BAE42218.1; -; mRNA.
DR   EMBL; AK171265; BAE42353.1; -; mRNA.
DR   EMBL; BC003730; AAH03730.1; -; mRNA.
DR   CCDS; CCDS15367.1; -.
DR   RefSeq; NP_035007.1; NM_010877.5.
DR   RefSeq; XP_006529299.1; XM_006529236.3.
DR   AlphaFoldDB; O70145; -.
DR   SMR; O70145; -.
DR   BioGRID; 201702; 3.
DR   IntAct; O70145; 2.
DR   STRING; 10090.ENSMUSP00000140404; -.
DR   iPTMnet; O70145; -.
DR   PhosphoSitePlus; O70145; -.
DR   SwissPalm; O70145; -.
DR   EPD; O70145; -.
DR   jPOST; O70145; -.
DR   MaxQB; O70145; -.
DR   PaxDb; O70145; -.
DR   PeptideAtlas; O70145; -.
DR   PRIDE; O70145; -.
DR   ProteomicsDB; 252650; -.
DR   Antibodypedia; 702; 291 antibodies from 30 providers.
DR   DNASU; 17970; -.
DR   Ensembl; ENSMUST00000027754; ENSMUSP00000027754; ENSMUSG00000026480.
DR   Ensembl; ENSMUST00000186568; ENSMUSP00000140404; ENSMUSG00000026480.
DR   GeneID; 17970; -.
DR   KEGG; mmu:17970; -.
DR   UCSC; uc007czm.1; mouse.
DR   CTD; 4688; -.
DR   MGI; MGI:97284; Ncf2.
DR   VEuPathDB; HostDB:ENSMUSG00000026480; -.
DR   eggNOG; KOG4225; Eukaryota.
DR   GeneTree; ENSGT00530000063843; -.
DR   HOGENOM; CLU_041290_0_0_1; -.
DR   InParanoid; O70145; -.
DR   OMA; SKVNQDW; -.
DR   OrthoDB; 431898at2759; -.
DR   PhylomeDB; O70145; -.
DR   TreeFam; TF329087; -.
DR   Reactome; R-MMU-1222556; ROS and RNS production in phagocytes.
DR   Reactome; R-MMU-1236973; Cross-presentation of particulate exogenous antigens (phagosomes).
DR   Reactome; R-MMU-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-MMU-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-MMU-5668599; RHO GTPases Activate NADPH Oxidases.
DR   Reactome; R-MMU-9013149; RAC1 GTPase cycle.
DR   Reactome; R-MMU-9013404; RAC2 GTPase cycle.
DR   Reactome; R-MMU-9013423; RAC3 GTPase cycle.
DR   BioGRID-ORCS; 17970; 2 hits in 72 CRISPR screens.
DR   ChiTaRS; Ncf2; mouse.
DR   PRO; PR:O70145; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; O70145; protein.
DR   Bgee; ENSMUSG00000026480; Expressed in granulocyte and 64 other tissues.
DR   ExpressionAtlas; O70145; baseline and differential.
DR   Genevisible; O70145; MM.
DR   GO; GO:0001669; C:acrosomal vesicle; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0043020; C:NADPH oxidase complex; ISO:MGI.
DR   GO; GO:0008022; F:protein C-terminus binding; ISO:MGI.
DR   GO; GO:0031267; F:small GTPase binding; IPI:MGI.
DR   GO; GO:0016175; F:superoxide-generating NAD(P)H oxidase activity; IDA:MGI.
DR   GO; GO:0016176; F:superoxide-generating NADPH oxidase activator activity; ISO:MGI.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; ISO:MGI.
DR   GO; GO:0006742; P:NADP catabolic process; ISO:MGI.
DR   GO; GO:0006909; P:phagocytosis; IEA:InterPro.
DR   GO; GO:0045777; P:positive regulation of blood pressure; ISO:MGI.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISO:MGI.
DR   GO; GO:1903426; P:regulation of reactive oxygen species biosynthetic process; ISO:MGI.
DR   GO; GO:0045730; P:respiratory burst; IEA:InterPro.
DR   GO; GO:0009749; P:response to glucose; ISO:MGI.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISO:MGI.
DR   GO; GO:0014070; P:response to organic cyclic compound; ISO:MGI.
DR   GO; GO:0042554; P:superoxide anion generation; IDA:MGI.
DR   GO; GO:0006801; P:superoxide metabolic process; ISO:MGI.
DR   CDD; cd06406; PB1_P67; 1.
DR   CDD; cd11871; SH3_p67phox_N; 1.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR034889; P67-PHOX.
DR   InterPro; IPR035546; p67phox_SH3_1.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR034885; PB1_P67.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR001440; TPR_1.
DR   InterPro; IPR019734; TPR_repeat.
DR   PANTHER; PTHR15175:SF3; PTHR15175:SF3; 1.
DR   Pfam; PF00564; PB1; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   Pfam; PF00515; TPR_1; 1.
DR   Pfam; PF13181; TPR_8; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00666; PB1; 1.
DR   SMART; SM00326; SH3; 2.
DR   SMART; SM00028; TPR; 3.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   SUPFAM; SSF50044; SSF50044; 2.
DR   PROSITE; PS51745; PB1; 1.
DR   PROSITE; PS50002; SH3; 2.
DR   PROSITE; PS50005; TPR; 3.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Phosphoprotein; Reference proteome; Repeat; SH3 domain;
KW   TPR repeat.
FT   CHAIN           1..525
FT                   /note="Neutrophil cytosol factor 2"
FT                   /id="PRO_0000312227"
FT   REPEAT          37..70
FT                   /note="TPR 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          71..104
FT                   /note="TPR 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          121..154
FT                   /note="TPR 3"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          240..299
FT                   /note="SH3 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          350..428
FT                   /note="PB1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01081"
FT   DOMAIN          456..515
FT                   /note="SH3 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          304..343
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          437..457
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        313..327
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         233
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         324
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   CONFLICT        31
FT                   /note="E -> A (in Ref. 2; BAE42353/BAE42218/BAE42065/
FT                   BAE33191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        324
FT                   /note="S -> N (in Ref. 2; BAE32002)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   525 AA;  59485 MW;  663DB6B52D790F76 CRC64;
     MSLAEAIRLW NEGVLAADKK DWKGALEAFS EVQDPHSRIC FNIGCVNTIL ENLQAAEQAF
     TKSINRDKHS AVAYFQRGML YYRMEKYDLA IKDLKEALTQ LRGNQLIDYK ILGLQFKLFA
     CEVLYNIALM HAKKEEWKKA EEQLALATNM KSEPRHSKID KAMESIWKQK LFEPVVIPVG
     RLFRPNERQV AQLAKKDYLG KATVVASVVH QDNFSGFAPL QPQSAEPPPR PKTPEIFRAL
     EGEAHRVLFG FVPETPEELQ VMPGNIVFVL KKGSDNWATV MFNGQKGLVP CNYLEPVELR
     IHPQSQPQED TSPESDIPPP PNSSPPGRLQ LSPGHKQKEP KELKLSVPMP YMLKVHYKYT
     VVMETRLGLP YSQLRNMVSK KLALSPEHTK LSYRRRDSHE LLLLSEESMK DAWGQVKNYC
     LTLWCEHTVG DQGLIDEPIQ RENSDASKQT TEPQPKEGTQ VVAIFSYEAA QPEDLEFVEG
     DVILVLSHVN EEWLEGECKG KVGIFPKAFV EGCAAKNLEG IPREV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024